Skip to main content

Scilex Holding Co

SCLX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001820190

No open-market purchases or sales by Scilex Holding Co insiders were filed in the last 90 days; 73 institutions reported holding it in 13F filings for Q2 2026, worth $5.48M in total; no superinvestor holds it.

Other share classesSCLXW

Q1 2025 vs. Q4 2024

How the institutions holding Scilex Holding Co changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of SCLX: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders102185−16
Shares49.1M345.4M−3.70M (−7.5%)
Value$20.9M$1$11.3M−$9.65M (−46.1%)

1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (5)

Institutions that held Scilex Holding Co at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to SCLX in Q1 2025
InstitutionSharesValue% of portfolio
B. Riley Financial, Inc.434,515$108.0K0.14%
Prudential Financial Inc154,026$38.3K0.00%
Renaissance Technologies LLC66,500$16.5K0.00%
Virtus Investment Advisers, Inc.17,955$4.24K0.00%
Avion Wealth2,000$00.00%

Sold out (21)

Institutions that held Scilex Holding Co at the end of Q4 2024 and filed for Q1 2025 without it.

Not filed for Q1 2025 yet (1)

Institutions that held Scilex Holding Co at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SCLX in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Global Retirement Partners, LLC3$1